UM Miller School of Medicine: A Promising Gene Therapy for Older Children With Duchenne Muscular Dystrophy
December 27, 2024
December 27, 2024
MIAMI, Florida, Dec. 27 (TNSres) -- The University of Miami Miller School of Medicine issued the following news:
A new gene therapy, ELEVIDYS, has been approved to treat older Duchenne muscular dystrophy (DMD) patients.
UHealth--University of Miami Health System and Holtz Children's Hospital physicians are playing a major role in getting them access.
The therapy delivers a functional micro-gene to muscle cells, potentially arresting DMD progression and . . .
A new gene therapy, ELEVIDYS, has been approved to treat older Duchenne muscular dystrophy (DMD) patients.
UHealth--University of Miami Health System and Holtz Children's Hospital physicians are playing a major role in getting them access.
The therapy delivers a functional micro-gene to muscle cells, potentially arresting DMD progression and . . .